Comparison of two therapeutic protocols in patients with antiphospholipid antibodies and recurrent miscariages
Open accessAbstract
AIM: To compare the effects of two therapeutic protocols for the patients with recurrent miscarriages associated with the presence of antiphospholipid (anticardiolipin) antibodies. METHODS: A prospective observational study included 20 patients with antiphospholipid antibodies in the first group who received low-molecular heparin and aspirin. The second group of 20 patients, in addition to this therapy, received immunotherapy (intravenous immunoglobulin). Aspirin was administered at the time of a positive pregnancy test, and low-molecular heparin not before the fetal heart activity registration by ultrasound. Intravenous immunoglobulin was given prior to the conception or at the beginning of the pregnancy. We compared these groups according to the pregnancy outcomes and the occurrence of complications during pregnancy, using standard statistical tests. RESULTS: The rate of positive gestational outcome in the patients treated with aspirin and low-molecular heparin was 85% (17/20), and in the second group it was 90% (18/20). There was no significant difference in pregnancy outcomes between these groups (p > 0.05), except for the occurence of preeclampsia and thrombocytopenia, which were recorded only in the aspirin and low-molecular heparin group, but with no statistical significance (p > 0.05) compared to the second group, which received immunoglobulin additionally. CONCLUSION: There was no significant difference (p > 0.05) in pregnancy outcomes between the two studied therapeutic protocols, but the therapy with aspirin and low-molecular heparin was cheaper and easier to apply than the therapy with immunoglobulins. The results of our study confirmed that the final pathogenic mechanisms in recurrent fetal miscarriages were inflammation and thrombosis of the uteroplacental blood vessels.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
IVIG was not associated with a higher proportion of live births compared with conventional treatment in three small observational studies, though confounding by indication may have occurred.
“Use of IVIG was not associated with a higher proportion of live births compared with conventional treatment in three small observational studies58–60 that directly addressed this question, although confounding by indication may have occurred.”
From EULAR recommendations for the management of antiphospholipid syndrome in adults (2019) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Kutteh, W. H. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70610-5 · Cited by 807 · see citing works
The Regulation of Natural Anticoagulant Pathways
Esmon, C. T. (1987) · Science · doi:10.1126/science.3029867 · Cited by 706 · see citing works
Use of Antithrombotic Agents During Pregnancy
Ginsberg, J. S., & Hirsh, J. (1995) · CHEST Journal · doi:10.1378/chest.108.4_supplement.305s · Cited by 660 · see citing works
(1992) · PubMed · Cited by 434 · see citing works
More to “heparin” than anticoagulation
Lindahl, U., Lidholt, K., Spillmann, D., & Kjellén, L. (1994) · Thrombosis Research · doi:10.1016/0049-3848(94)90136-8 · Cited by 340 · see citing works
Branch, D. W., Peaceman, A. M., Druzin, M. L., Silver, R. K., El-Sayed, Y. Y., Silver, R. M., Esplin, M. S., Spinnato, J. A., & Harger, J. H. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(00)70500-x · Cited by 315 · see citing works
Rai, R., Clifford, K., Cohen, H., & Regan, L. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a135907 · Cited by 301 · see citing works
Pattison, N. S., Chamley, L., Birdsall, M. A., Zanderigo, A., Liddell, H. S., & McDougall, J. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.106754 · Cited by 290 · see citing works
Use of Antithrombotic Agents During Pregnancy
Ginsberg, J., Greer, I., & Hirsh, J. (2001) · CHEST Journal · doi:10.1378/chest.119.1_suppl.122s · Cited by 283 · see citing works
Sher, G., Feinman, M. A., Zouves, C., Kuttner, G., Maassarani, G., Salem, R. D., Matzner, W., Ching, W., & Chong, P. (1994) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a138437 · Cited by 185 · see citing works
LUPUS ANTICOAGULANT AND RECURRENT FETAL LOSS: SUCCESSFUL TREATMENT WITH GAMMAGLOBULIN
Carreras, L., Pérez, G., Vega, H. R., & CASAVILLA, F. A. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92859-0 · Cited by 173 · see citing works
Kutteh, W. H., Yetman, D. L., Chantilis, S. J., & Crain, J. L. (1997) · Human Reproduction · doi:10.1093/humrep/12.6.1171 · Cited by 144 · see citing works
Horn, J. T.-V., Craven, C., Ward, K., Branch, D. W., & Silver, R. M. (2004) · Placenta · doi:10.1016/j.placenta.2003.12.006 · Cited by 114 · see citing works
Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy
Spinnato, J. A., Clark, A. L., Pierangeli, S. S., & Harris, E. N. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90595-2 · Cited by 114 · see citing works
Heparin/heparan sulfate is involved in attachment and spreading of mouse embryos in vitro
Farach‐Carson, M. C., Tang, J., Decker, G. L., & Carson, D. D. (1987) · Developmental Biology · doi:10.1016/0012-1606(87)90398-8 · Cited by 111 · see citing works
Antiphospholipid antibodies in women at risk for preeclampsia
Branch, D. W., Porter, T. F., Rittenhouse, L., Caritis, S. N., Sibai, B. M., Hogg, B. B., Lindheimer, M. D., Klebanoff, M. A., MacPherson, C., VanDorsten, J. P., et al. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.113846 · Cited by 107 · see citing works
The antiphospholipid syndrome: a syndrome in evolution.
Asherson, R. A., & Cervera, R. (1992) · Annals of the Rheumatic Diseases · doi:10.1136/ard.51.2.147 · Cited by 101 · see citing works
Vaquero, E., Valensise, H. C. C., Menghini, S., Pierro, G. D., Romaninï, C., Lazzarin, N., & Cesa, F. (2001) · American Journal of Reproductive Immunology · doi:10.1111/j.8755-8920.2001.450309.x · Cited by 99 · see citing works
Lassere, M. N., & Empson, M. B. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.08.006 · Cited by 79 · see citing works
Sletnes, K. E., Wislöff, F., Moe, N., & Dale, P. O. (1992) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016349209007966 · Cited by 61 · see citing works
Ermel, L. D., Marshburn, P. B., & Kutteh, W. H. (1995) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1995.tb01133.x · Cited by 59 · see citing works
Gromnica‐Ihle, E., & Schössler, W. (2000) · International Archives of Allergy and Immunology · doi:10.1159/000024425 · Cited by 31 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Gromnica-Ihle E, Schossler W. Antiphospholipid syn- drome. Int Arch Allergy Immunol 2000; 123(1): 67-76.
Cited by
Sorted by citations
EULAR recommendations for the management of antiphospholipid syndrome in adults
Tektonidou, M. G., Andreoli, L., Limper, M., Amoura, Z., Cervera, R., Costedoat-Chalumeau, N., Cuadrado, M. J., Dörner, T., Ferrer-Oliveras, R., Hambly, K., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215213 · Cited by 1,261 · see citing works
Russell, M., Dey, M., Flint, J., Davie, P., Allen, A., Crossley, A., Frishman, M., Gayed, M., Hodson, K. K., Khamashta, M. A., et al. (2022) · Lara D. Veeken · doi:10.1093/rheumatology/keac551 · Cited by 237 · see citing works
Tektonidou, M. G., Andréoli, L., Limper, M., Tincani, A., & Ward, M. M. (2019) · RMD Open · doi:10.1136/rmdopen-2019-000924 · Cited by 99 · see citing works
Tenti, S., Cheleschi, S., Guidelli, G. M., Galeazzi, M., & Fioravanti, A. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.11.009 · Cited by 82 · see citing works
Management of antiphospholipid syndrome
Tuthill, J. I., & Khamashta, M. A. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.05.002 · Cited by 78 · see citing works
The treatment of anti-phospholipid syndrome: A comprehensive clinical approach
Chighizola, C. B., Andréoli, L., Gerosa, M., Tincani, A., Ruffatti, A., & Meroni, P. L. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.02.003 · Cited by 66 · see citing works
Management of Antiphospholipid Syndrome in Pregnancy
Petri, M., & Qazi, U. (2006) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2006.05.007 · Cited by 50 · see citing works
Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine
Velikova, T. V., Sekulovski, M., Bogdanova, S., Vasilev, G., Peshevska-Sekulovska, M., Miteva, D., & Georgiev, T. (2023) · Antibodies · doi:10.3390/antib12010020 · Cited by 46 · see citing works
The role of high-dose intravenous immunoglobulin in rheumatology
Vaitla, P., & McDermott, E. M. (2010) · Lara D. Veeken · doi:10.1093/rheumatology/keq021 · Cited by 31 · see citing works
Saab, W., Seshadri, S., Huang, C., Alsubki, L., Sung, N., & Kwak-Kim, J. Y.-H. (2021) · American Journal of Reproductive Immunology · doi:10.1111/aji.13395 · Cited by 26 · see citing works
Cáliz, R., Fontecha, P. D. D. C., Galindo-Izquierdo, M., Longo, F. J. L., Zamora, M. Á. M., Santamaría, A., Pliego, O. A., Lozano, M. J. C., Beltrán, M. P. D., Ortells, L. C., et al. (2019) · Reumatología Clínica · doi:10.1016/j.reuma.2018.11.004 · Cited by 10 · see citing works
Grossesse et anticorps antiphospholipides
Guern, V. L., & Goffinet, F. (2008) · La Presse Médicale · doi:10.1016/j.lpm.2008.08.001 · Cited by 9 · see citing works
Cáliz, R., Fontecha, P. D. D. C., Galindo-Izquierdo, M., Longo, F. J. L., Zamora, M. Á. M., Santamaría, A., Pliego, O. A., Lozano, M. J. C., Beltrán, M. P. D., Ortells, L. C., et al. (2019) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2018.11.013 · Cited by 4 · see citing works
Еремеева, Д. Р., & Зайнулина, М. С. (2024) · Obstetrics Gynecology and Reproduction · doi:10.17749/2313-7347/ob.gyn.rep.2024.479 · Cited by 3 · see citing works
Crotti, C., Ughi, N., Beretta, E., Brucato, A. L., Carrara, G., Chimenti, M. S., Conigliaro, P., Crisafulli, F., Cuomo, G., Poi, E. D., et al. (2025) · Reumatismo · doi:10.4081/reumatismo.2025.1752 · Cited by 2 · see citing works
Treatments and new perspectives of Antiphospholipid Syndrome in pregnancy
Delorenzi, J. C. B., Cunha, M. R., Vergara, G. A., & Mary, C. S. S. (2018) · Medical Research Archives · doi:10.18103/mra.v6i5.1783 · Cited by 1 · see citing works
Chapter 17 Treatment of Late Pregnancy Complications in the Antiphospholipid Syndrome
Nassar, A. H., Uthman, I. W., & Khamashta, M. A. (2009) · Technical report · doi:10.1016/s1571-5078(08)00417-0
Treatment of Pregnancy Complications in Antiphospholipid Syndrome
Nassar, A. H., Uthman, I. W., Eid, J., & Khamashta, M. A. (2016) · Technical report · doi:10.1016/b978-0-444-63655-3.00018-1
Intravenous Immunoglobulin Treatment in Rheumatic Diseases
Fioravanti, A., & Tenti, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814307-0.00061-x
Veselinović, M., Lucic, A. T., Jakovljevic, V. L., & Aničić, A. (2019) · Medicinski casopis · doi:10.5937/mckg53-23292
- Authors
- Jeremic, K., Pervulov, M., Gojnic, M., Dukanac, J., Ljubic, A., & Stojnic, J.
- Affiliations
- Clinical Center of Serbia, Institute of Gynecology and Obstetrics, Belgrade
- ista
- Venue
- Vojnosanitetski pregled
- Publisher
- National Library of Serbia
- Published
- 2005
- Volume
- 62
- Issue
- 6
- Pages
- 435-439
- ISSN
- 0042-8450 (ISSN-L)
- 2406-0720
- OpenAlex
- W2158042059
- Cited by
- 20
- References
- 22
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2019: 6 · 2018: 2 · 2016: 1 · 2015: 1
- FWCI
- 0.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Vojnosanitetski pregled (publishedVersion, cc-by-sa)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Keywords
- recurrent pregnancy loss, antiphospholipid antibodies, anticardiolipin antibodies, low molecular weight heparin, aspirin, intravenous immunoglobulin, immunotherapy, pregnancy outcomes, preeclampsia, thrombocytopenia, inflammation
- MeSH terms
- Abortion, Habitual, Adult, Aspirin, Drug Therapy, Combination, Female, Fibrinolytic Agents, Heparin, Humans, Pregnancy, Pregnancy Outcome, Antiphospholipid Syndrome, Immunoglobulins, Intravenous, Antibodies, Antiphospholipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
